I Davidkin

Summary

Affiliation: National Public Health Institute
Country: Finland

Publications

  1. ncbi IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy
    Mikko Paunio
    Ministry of Social Affairs and Health, PO Box 33, 00023 Government, Finland
    Expert Opin Pharmacother 4:1215-25. 2003
  2. ncbi Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts
    I Davidkin
    National Public Health Institute, Helsinki, Finland
    Vaccine 16:2052-7. 1998
  3. doi Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up
    Irja Davidkin
    National Public Health Institute, University of Helsinki, Helsinki, Finland
    J Infect Dis 197:950-6. 2008
  4. ncbi Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella
    Irja Davidkin
    National Public Health Institute, Helsinki, Finland
    J Infect Dis 191:719-23. 2005
  5. ncbi Molecular epidemiology of hepatitis A in St. Petersburg, Russia, 1997-2003
    Irja Davidkin
    National Public Health Institute, Helsinki, Finland
    J Med Virol 79:657-62. 2007
  6. ncbi Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland
    I Davidkin
    National Public Health Institute, Helsinki, Finland
    Vaccine 18:3106-12. 2000
  7. ncbi Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children
    I Davidkin
    National Public Health Institute, Helsinki University Central Hospital, Helsinki, Finland
    J Infect Dis 178:1567-70. 1998
  8. ncbi Mumps and rubella eliminated from Finland
    H Peltola
    Hospital for Children and Adolescents, PO Box 281, FIN 00029 HUS, Helsinki, Finland
    JAMA 284:2643-7. 2000
  9. ncbi Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up
    A Patja
    Hospital for Children and Adolescents, Helsinki University Central Hospital, Finland
    Pediatr Infect Dis J 19:1127-34. 2000
  10. doi Epidemiology of hepatitis A in Finland in 1990-2007
    Mia Broman
    National Institute for Health and Welfare, Helsinki, Finland
    J Med Virol 82:934-41. 2010

Collaborators

Detail Information

Publications18

  1. ncbi IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy
    Mikko Paunio
    Ministry of Social Affairs and Health, PO Box 33, 00023 Government, Finland
    Expert Opin Pharmacother 4:1215-25. 2003
    ..The results may have wide implications on global measles eradication efforts. The potential of IgG avidity measurement in complex postvaccination measles epidemiology is discussed...
  2. ncbi Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts
    I Davidkin
    National Public Health Institute, Helsinki, Finland
    Vaccine 16:2052-7. 1998
    ..It is important to follow how long the protection achieved by the present vaccine programme will last after elimination of indigenous measles...
  3. doi Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up
    Irja Davidkin
    National Public Health Institute, University of Helsinki, Helsinki, Finland
    J Infect Dis 197:950-6. 2008
    ..The persistence of antibodies against measles, mumps, and rubella induced by the measles-mumps-rubella (MMR) vaccine and the kinetics of antibody decline after the second MMR vaccine dose were studied in the same cohort for 20 years...
  4. ncbi Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella
    Irja Davidkin
    National Public Health Institute, Helsinki, Finland
    J Infect Dis 191:719-23. 2005
    ....
  5. ncbi Molecular epidemiology of hepatitis A in St. Petersburg, Russia, 1997-2003
    Irja Davidkin
    National Public Health Institute, Helsinki, Finland
    J Med Virol 79:657-62. 2007
    ..The results indicate the usefulness of molecular epidemiological methods in studying changes in the circulating HAV strains and in tracing transmission routes...
  6. ncbi Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland
    I Davidkin
    National Public Health Institute, Helsinki, Finland
    Vaccine 18:3106-12. 2000
    ..A careful surveillance including serological follow-up is therefore very important...
  7. ncbi Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children
    I Davidkin
    National Public Health Institute, Helsinki University Central Hospital, Helsinki, Finland
    J Infect Dis 178:1567-70. 1998
    ..Each suspected vaccine failure requires laboratory confirmation to maintain reliable surveillance and control and to establish the specific etiology of the disease...
  8. ncbi Mumps and rubella eliminated from Finland
    H Peltola
    Hospital for Children and Adolescents, PO Box 281, FIN 00029 HUS, Helsinki, Finland
    JAMA 284:2643-7. 2000
    ..Despite the ongoing possibility of imported disease, major outbreaks probably can be avoided by maintaining high vaccination coverage and the 2-dose policy. JAMA. 2000;284:2643-2647...
  9. ncbi Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up
    A Patja
    Hospital for Children and Adolescents, Helsinki University Central Hospital, Finland
    Pediatr Infect Dis J 19:1127-34. 2000
    ..Several disorders have been attributed to measles-mumps-rubella (MMR) vaccination during the past decade. The aim of this prospective follow-up study was to identify serious adverse events causally related to MMR vaccination...
  10. doi Epidemiology of hepatitis A in Finland in 1990-2007
    Mia Broman
    National Institute for Health and Welfare, Helsinki, Finland
    J Med Virol 82:934-41. 2010
    ..The low seroprevalence, especially in younger age groups, makes the population vulnerable to infection, which can be compensated for by increasing the number of vaccinations...
  11. ncbi Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination
    Sari Jokinen
    Department of Viral Diseases and Immunology, National Public Health Institute, Helsinki, Finland
    J Infect Dis 196:861-7. 2007
    ..However, the persistence of MMR vaccine-induced immunity in the absence of endemic infection has remained unknown...
  12. ncbi Allergic reactions to measles-mumps-rubella vaccination
    A Patja
    Hospital for Children and Adolescents, Helsinki University Central Hospital, Finland
    Pediatrics 107:E27. 2001
    ..Other allergenic vaccine components have been sought, and gelatin has been suggested as one cause of allergic adverse events. The aim of this study was to further characterize the actual allergenic vaccine components...
  13. ncbi Epidemiology of rubella in Finland
    I Davidkin
    National Public Health Institute KTL, Helsinki, Finland
    Euro Surveill 9:13-4. 2004
    ..The last CRS case was recorded in 1986. As a result of the high coverage two dose MMR vaccination programme, rubella was successfully eliminated from Finland. How long the acquired protection will last remains to be seen...
  14. doi MMR vaccination and disease elimination: the Finnish experience
    Irja Davidkin
    National Institute for Health and Welfare, Department of Vaccination and Immune Protection, Helsinki, Finland
    Expert Rev Vaccines 9:1045-53. 2010
    ..Here we present an overview of MMR vaccinations and the Finnish experience of the MMR disease elimination process, and we describe surveillance activities in the era following elimination in Finland...
  15. doi Rabies control in Finland: a 12-year experience of human and veterinary surveillance
    R Rimhanen-Finne
    National Public Health Institute, 00300 Helsinki, Finland
    Zoonoses Public Health 56:496-501. 2009
    ..The import of animals from endemic areas, however, remains a risk, which can be reduced by increasing public awareness of the disease, vaccination of imported animals and better rabies control in endemic countries...
  16. doi Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme
    Heikki Peltola
    Helsinki University Central Hospital, Hospital for Children and Adolescents, Helsinki, Finland
    Lancet Infect Dis 8:796-803. 2008
    ..To maintain the absence of these diseases, the adopted policy should continue, but the country should also be prepared for prompt supplementary vaccinations in the case of epidemic outbreaks...
  17. pmc Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue
    Päivi Norja
    Department of Virology, Haartman Institute, University of Helsinki, FI 00290, Helsinki, Finland
    Proc Natl Acad Sci U S A 103:7450-3. 2006
    ....
  18. ncbi European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus
    Fernando de Ory
    Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    J Clin Virol 36:111-8. 2006
    ..The aim of the European Sero-Epidemiology Network (ESEN2) is to harmonise the serological surveillance of vaccine-preventable diseases in Europe...